Alpa Laboratories Limited (NSE:ALPA)
India · Delayed Price · Currency is INR 61.00
-1.62 (-2.59%)
Sep 11, 2026, 3:29 PM IST
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.3 billion as of September 11, 2026. Its market cap has decreased by -34.79% in one year.
Market Cap
1.30B
Enterprise Value
-55.65M
Revenue
1.11B
Ranking
n/a
PE Ratio
29.23
Stock Price
61.00
ChartMarket Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 1.30B, an increase of 12.57%. That is a compound annual growth rate of 0.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.30B | -20.59% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anlon Healthcare | 8.65B |
| Amanta Healthcare | 7.99B |
| Bafna Pharmaceuticals | 7.13B |
| Valiant Laboratories | 6.51B |
| Nectar Lifesciences | 2.33B |
| Brooks Laboratories | 1.86B |
| Par Drugs and Chemicals | 1.65B |
| Balaxi Pharmaceuticals | 1.31B |